Nu-Med Plus, Inc. Files Utility Patent for Low Cost Inhaled Nitric Oxide Technology
January 26, 2016 at 10:49 am EST
Share
Nu-Med Plus, Inc. announced filing for a utility patent as continuation of its provisional patent which covers its low cost Nitric Oxide delivery technology. Concentrating on progressive markets where there is clearly a defined need by the medical community; Nu-Med Plus has developed a Hospital NO Delivery System that may well reduce the existing high cost of Nitric Oxide treatment presently in use in hospitals. A utility patent has been applied for protecting this innovative advancement.
Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.
NU-MED PLUS, INC. 
